Clinical Trials Logo

Clinical Trial Details — Status: Active, not recruiting

Administrative data

NCT number NCT00831168
Other study ID # BEADI2005
Secondary ID
Status Active, not recruiting
Phase Phase 1/Phase 2
First received January 27, 2009
Last updated January 27, 2009
Start date October 2005
Est. completion date March 2009

Study information

Verified date January 2009
Source Confidential Enquiry into Maternal and Child Health
Contact n/a
Is FDA regulated No
Health authority England: The Confidential Enquiry into Maternal and Child Health
Study type Interventional

Clinical Trial Summary

BEADI is a dissemination trial, on standards of care of premature babies. The main objective of BEADI is to assess whether an innovative 'active' strategy for the dissemination of neonatal information (evidence reviews, interactive training workshop, benchmarking and feedback, and ongoing support) is more likely to lead to changes in policy and practice than the traditional (more passive) forms of dissemination in English neonatal units.

BEADI will focus on three areas of neonatal care for premature (22+0 to 26+6 weeks' gestation) babies born in England: timing of surfactant therapy, staffing for resuscitation at delivery, and temperature control (in line with the main Project 27/28 findings ). However, the approach is applicable to a wide variety of clinical policies and practice.

The BEADI study has been granted ethical approval by MREC to use a subset of data collected by EPICure2 up until 31st December 2006 (pre-intervention data). For the post-intervention data, ethical approval has been granted for CEMACH to continue data collection against the three clinical areas using a subset of data items captured in the PN:E2 form, for the three month period between 1st January - 31st March 2007. Local research and development departments of each trust have also been contacted.


Recruitment information / eligibility

Status Active, not recruiting
Enrollment 200
Est. completion date March 2009
Est. primary completion date March 2009
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Both
Age group 22 Weeks to 27 Weeks
Eligibility Inclusion Criteria:

- Hospital staff : Lead neonatologist for clinical governance in each maternity hospital in England.

- Babies born in England before 27 weeks gestation between January 2006 - 31st March 2007

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research


Related Conditions & MeSH terms


Intervention

Behavioral:
Effects of Active Dissemination
No medical intervention involved. It is purely information based.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Confidential Enquiry into Maternal and Child Health

Outcome

Type Measure Description Time frame Safety issue
Primary Assess whether an innovative 'active' strategy for the dissemination of neonatal research findings, recs and national guidelines is more likely to lead to changes in policy and practice than the traditional,passive forms of dissemination in the UK. 3 years No